Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersInternal Medicine Physician in Placentia, CA
NPI: 1356874143Primary Employer
Quality Care Solution Inc.
qualitycaresolution.com
HQ Phone
Get M.D Mehran's Phone Numberphone_androidMobile
Get M.D Mehran's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99309Subsequent nursing facility visit, typically 25 minutes per day | 829 | 2,783 |
| 2 | 99308Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | 754 | 4,186 |
| 3 | 99306Initial nursing facility visit, typically 45 minutes per day | 572 | 672 |
| 4 | 99497Advance care planning by the physician or other qualified health care professional | 547 | 627 |
| 5 | 99316Nursing facility discharge management, more than 30 minutes | 221 | 254 |
Molecular profiling of single circulating tumor cells from lung cancer patients.
Authors: Heather Wakelee, Joel Neal, David Kurtz, Maximilian Diehn, Joseph Shrager
Journal: Proc Natl Acad Sci U S A
Publication Date: 2016-12-12
Whole-body simultaneous time-of-flight PET-MRI: early experience with clinical studies.
Authors: Shreyas Vasanawala
Publication Date: 2016-03-10
Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Authors: Amir Barkhodari
Publication Date: 2015-06-23
Lead Sponsor: Stanford University
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Positron Emission Tomography, DRUG: Fludeoxyglucose F-18, PROCEDURE: Contrast-enhanced Magnetic Resonance Imaging, DRUG: Fluorine F 18 Sodium Fluoride